Darolutamide improves OS in mHSPC

Presented By
Dr Matthew Smith, Massachusetts General Hospital Cancer Center, MA, USA
Trial
Phase 3, ARASENS
Conference
ASCO GU 2022

Third-line in mCRPC: CARD trial

Presented By
Prof. Ronald De Wit, Erasmus University Rotterdam, the Netherlands
Trial
CARD
Conference
ESMO 2019